Common Contracts

AGREEMENT AND PLAN OF MERGER by and among ADGERO BIOPHARMACEUTICALS HOLDINGS, INC., ADGERO ACQUISITION, INC., ADGERO BIOPHARMACEUTICALS, INC. and FRANK G. PILKIEWICZ, as the STOCKHOLDER REPRESENTATIVE Dated as of January 11, 2016

Agreement and Plan of Merger • February 14th, 2017 • Adgero Biopharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Agreement and Plan of Merger
• Filed
  February 14th, 2017
• Company
  Adgero Biopharmaceuticals Holdings, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS AGREEMENT AND PLAN OF MERGER, dated as of January 11, 2016 (this “Agreement”), by and among Adgero Biopharmaceuticals Holdings, Inc., a Delaware corporation (“Parent”), Adgero Acquisition, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), Adgero Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and Frank G. Pilkiewicz, as Stockholder Representative (the “Stockholder Representative”).

AGREEMENT AND PLAN OF MERGER by and among ADGERO BIOPHARMACEUTICALS HOLDINGS, INC., ADGERO ACQUISITION, INC., ADGERO BIOPHARMACEUTICALS, INC. and FRANK G. PILKIEWICZ, as the STOCKHOLDER REPRESENTATIVE Dated as of January 11, 2016

Agreement and Plan of Merger • November 3rd, 2016 • Adgero Biopharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Agreement and Plan of Merger
• Filed
  November 3rd, 2016
• Company
  Adgero Biopharmaceuticals Holdings, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS AGREEMENT AND PLAN OF MERGER, dated as of January 11, 2016 (this “Agreement”), by and among Adgero Biopharmaceuticals Holdings, Inc., a Delaware corporation (“Parent”), Adgero Acquisition, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), Adgero Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and Frank G. Pilkiewicz, as Stockholder Representative (the “Stockholder Representative”).

AGREEMENT AND PLAN OF MERGER by and among CORBUS PHARMACEUTICALS Holdings, Inc, cORBUS pHARMACEUTICALS ACQUISITION, Inc., and JB THERAPEUTICS, INC. Dated as of March 27, 2014

Agreement and Plan of Merger • September 3rd, 2014 • Corbus Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Agreement and Plan of Merger
• Filed
  September 3rd, 2014
• Company
  Corbus Pharmaceuticals Holdings, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS AGREEMENT AND PLAN OF MERGER, dated as of March 27, 2014 (this “Agreement”), by and among Corbus Pharmaceuticals Holdings, Inc., a Delaware corporation (“Parent”), Corbus Pharmaceuticals Acquisition, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), JB Therapeutics, Inc., a Delaware corporation (the “Company”), and Yuval Cohen, as Stockholder Representative (the “Stockholder Representative”).